Last updated on January 2020

Fixed Dose Triple Therapy in Severe Chronic Obstructive Pulmonary Disease in a Real World Setting


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Chronic Obstructive Lung Disease
  • Age: Between 40 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patient has provided written informed consent
  • Patient is aged 40 years or older at time of initiation of Trimbow treatment
  • Patient is diagnosed with moderate or severe chronic obstructive pulmonary disease confirmed by spirometry (post-bronchodilation) based on the Global Initiative for chronic obstructive lung disease (GOLD) 2018 classification
  • Patient treated with double inhalation or free triple therapy (using at least 2 devices) who are prescribed Trimbow

Exclusion Criteria:

Hypersensitivity to the active substances or to any of the excipients listed below:

  • Ethanol anhydrous
  • Hydrochloric acid
  • Norflurane (propellant)

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.